Creation of a large-scale US Medical Science Liaison (MSL) program to assist in aggregating quantitative and qualitative data to support a prospective NDA to the FDA by raising educational awareness to key opinion leaders within the fields of Neurology and Geriatrics.
Further creation of a qualitative approach to leveraging MSLs to connect the patient journey to community experts and establish informal networks.
Create visibility and understanding of current guidelines and therapies in a challenging therapeutic field of study, mapping influencer networks and bringing back medical insights to the organization.
Recruit MSLs with a background in neurodegenerative diseases, who have similar experience in building national networks within the Alzheimer’s disease space.
Work collaboratively with USMA to develop a collaborative training program for disease specific guidance, outlining a comprehensive onboarding schedule.
Validate current list of HCPs and maintain an up-to-date list of HCPs, as determined by the client.
Support the educational initiatives, and collection of insights from KOLs, on strategic initiatives conducted at prioritized accounts and/or institutions.
29 MSLs hired, 2 MSL managers (comprising 90% terminal degrees) – US coverage with a broad educational outreach with a scalable model to adjust to more FTEs based on the client.
MSLs are actively engaged on multiple functional areas of influence:
CASE STUDY (US) The Challenge A client approached us to support their Phase III clinical trials. They needed to...
Read moreCASE STUDY (US) Hired-trained 6 MSLs, team manager for medical device co leading to successful launch and expansion of new FDA-approved applications.
Read more